Polymorphism of hormone synthesis and metabolizing genes and breast cancer risk: A multigenic case-control study

Endogenous and exogenous hormones influence breast cancer risk including estrogen biosynthesis pathway, vitamin D receptor pathway, and the androgen receptor pathway. Genes involved in these pathways are CYP17, which encodes an enzyme involved in estradiol and testosterone synthesis, androgen recept...

Full description

Bibliographic Details
Main Authors: Anurupa Chakraborty, Ashwani K Mishra, Sunita Saxena
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Biomedical Research Journal
Subjects:
Online Access:http://www.brjnmims.org/article.asp?issn=2349-3666;year=2016;volume=3;issue=1;spage=73;epage=87;aulast=Chakraborty;type=0
_version_ 1818646896350068736
author Anurupa Chakraborty
Ashwani K Mishra
Sunita Saxena
author_facet Anurupa Chakraborty
Ashwani K Mishra
Sunita Saxena
author_sort Anurupa Chakraborty
collection DOAJ
description Endogenous and exogenous hormones influence breast cancer risk including estrogen biosynthesis pathway, vitamin D receptor pathway, and the androgen receptor pathway. Genes involved in these pathways are CYP17, which encodes an enzyme involved in estradiol and testosterone synthesis, androgen receptor (AR), which binds testosterone and DHT and regulates breast cell growth and the vitamin D receptor (VDR), which binds vitamin D and down-regulates breast growth.The current study was proposed to determine whether polymorphisms in the CAG repeat in exon 1 of AR, MspAI T > C substitution of CYP17, and ApaI, 7aqI, poly-A repeat in the VDR gene contribute to breast cancer risk. Logistic regression models were used to evaluate individual and joint contributions of genotypes to breast cancer risk.Seventy (70) breast cancer patients and eighty healthy women (80) were recruited for the study. PCR based RFLP and fragment analysis assays were used to determine genotypes of hormone metabolizing genes. Considering CYP17 A2 allele, VDR Poly-(A) L, and AR ≥ 20 CAG repeats as high risk alleles, a multigenic model of breast cancer susceptibility was developed to identify women who carry a combination of alleles to put them at relatively higher risk to develop breast cancer. All the high-risk genotypes were positively associated with risk. The risk among women carrying three high-risk alleles was OR:4.68 [95% confidence interval (CI), 0.77-28.0; p for trend = 0.10] compared with those who carried none. The conditional logistic regression analysis revealed that the heterozygous TC genotype for CYP17 and AR1AR2 of AR, imparted significantly fourfold risk for the breast cancer risk, in comparison to the referent genotype TT and AR1AR1 [adjusted ORs:3.705(1.236,11.106), p = 0.019] and [4.391(1.324,14.557), p = 0.016], respectively. Gene X Gene interaction showed that the combinations TC*AA, TC*Aa, TC*aa and CC*Aa imparted significantly four to fifteen fold more risk for the breast cancer [(4.377 (1.159, 16.520), p = 0.029); 4.041(1.092, 14.956), p = 0.036); (15.071(0.975, 232.81), p = 0.052); (4.151(1.053, 16.371), p = 0.042), respectively)]. Genes involved in hormone synthesis and metabolizing pathway may play a role in breast cancer development as supported by the multigenic model of breast cancer susceptibility.
first_indexed 2024-12-17T00:53:55Z
format Article
id doaj.art-8db59fd9125c408ebb4f9cc9075ab49b
institution Directory Open Access Journal
issn 2349-3666
2349-3674
language English
last_indexed 2024-12-17T00:53:55Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Biomedical Research Journal
spelling doaj.art-8db59fd9125c408ebb4f9cc9075ab49b2022-12-21T22:09:40ZengWolters Kluwer Medknow PublicationsBiomedical Research Journal2349-36662349-36742016-01-0131738710.4103/2349-3666.240606Polymorphism of hormone synthesis and metabolizing genes and breast cancer risk: A multigenic case-control studyAnurupa ChakrabortyAshwani K MishraSunita SaxenaEndogenous and exogenous hormones influence breast cancer risk including estrogen biosynthesis pathway, vitamin D receptor pathway, and the androgen receptor pathway. Genes involved in these pathways are CYP17, which encodes an enzyme involved in estradiol and testosterone synthesis, androgen receptor (AR), which binds testosterone and DHT and regulates breast cell growth and the vitamin D receptor (VDR), which binds vitamin D and down-regulates breast growth.The current study was proposed to determine whether polymorphisms in the CAG repeat in exon 1 of AR, MspAI T > C substitution of CYP17, and ApaI, 7aqI, poly-A repeat in the VDR gene contribute to breast cancer risk. Logistic regression models were used to evaluate individual and joint contributions of genotypes to breast cancer risk.Seventy (70) breast cancer patients and eighty healthy women (80) were recruited for the study. PCR based RFLP and fragment analysis assays were used to determine genotypes of hormone metabolizing genes. Considering CYP17 A2 allele, VDR Poly-(A) L, and AR ≥ 20 CAG repeats as high risk alleles, a multigenic model of breast cancer susceptibility was developed to identify women who carry a combination of alleles to put them at relatively higher risk to develop breast cancer. All the high-risk genotypes were positively associated with risk. The risk among women carrying three high-risk alleles was OR:4.68 [95% confidence interval (CI), 0.77-28.0; p for trend = 0.10] compared with those who carried none. The conditional logistic regression analysis revealed that the heterozygous TC genotype for CYP17 and AR1AR2 of AR, imparted significantly fourfold risk for the breast cancer risk, in comparison to the referent genotype TT and AR1AR1 [adjusted ORs:3.705(1.236,11.106), p = 0.019] and [4.391(1.324,14.557), p = 0.016], respectively. Gene X Gene interaction showed that the combinations TC*AA, TC*Aa, TC*aa and CC*Aa imparted significantly four to fifteen fold more risk for the breast cancer [(4.377 (1.159, 16.520), p = 0.029); 4.041(1.092, 14.956), p = 0.036); (15.071(0.975, 232.81), p = 0.052); (4.151(1.053, 16.371), p = 0.042), respectively)]. Genes involved in hormone synthesis and metabolizing pathway may play a role in breast cancer development as supported by the multigenic model of breast cancer susceptibility.http://www.brjnmims.org/article.asp?issn=2349-3666;year=2016;volume=3;issue=1;spage=73;epage=87;aulast=Chakraborty;type=0breast cancercyp17 genevitamin d receptor geneandrogen receptor genepolymorphismmultigenic model
spellingShingle Anurupa Chakraborty
Ashwani K Mishra
Sunita Saxena
Polymorphism of hormone synthesis and metabolizing genes and breast cancer risk: A multigenic case-control study
Biomedical Research Journal
breast cancer
cyp17 gene
vitamin d receptor gene
androgen receptor gene
polymorphism
multigenic model
title Polymorphism of hormone synthesis and metabolizing genes and breast cancer risk: A multigenic case-control study
title_full Polymorphism of hormone synthesis and metabolizing genes and breast cancer risk: A multigenic case-control study
title_fullStr Polymorphism of hormone synthesis and metabolizing genes and breast cancer risk: A multigenic case-control study
title_full_unstemmed Polymorphism of hormone synthesis and metabolizing genes and breast cancer risk: A multigenic case-control study
title_short Polymorphism of hormone synthesis and metabolizing genes and breast cancer risk: A multigenic case-control study
title_sort polymorphism of hormone synthesis and metabolizing genes and breast cancer risk a multigenic case control study
topic breast cancer
cyp17 gene
vitamin d receptor gene
androgen receptor gene
polymorphism
multigenic model
url http://www.brjnmims.org/article.asp?issn=2349-3666;year=2016;volume=3;issue=1;spage=73;epage=87;aulast=Chakraborty;type=0
work_keys_str_mv AT anurupachakraborty polymorphismofhormonesynthesisandmetabolizinggenesandbreastcancerriskamultigeniccasecontrolstudy
AT ashwanikmishra polymorphismofhormonesynthesisandmetabolizinggenesandbreastcancerriskamultigeniccasecontrolstudy
AT sunitasaxena polymorphismofhormonesynthesisandmetabolizinggenesandbreastcancerriskamultigeniccasecontrolstudy